昊帆生物
(301393)
| 流通市值：17.95亿 | | | 总市值：48.03亿 |
| 流通股本：4035.90万 | | | 总股本：1.08亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 361,081,038.91 | 352,522,855.53 | 929,428,407.98 | 1,734,899,973.95 |
| 应收票据及应收账款 | 97,164,584.32 | 99,133,610.78 | 95,872,320.48 | 74,828,576.82 |
| 其中：应收票据 | 3,951,011.35 | 1,047,433.46 | 2,632,501 | 1,471,780 |
| 应收账款 | 93,213,572.97 | 98,086,177.32 | 93,239,819.48 | 73,356,796.82 |
| 应收款项融资 | 1,174,605.89 | 2,078,532.33 | 2,785,405 | 1,044,164 |
| 预付款项 | 2,847,673.92 | 8,583,560.16 | 2,663,622.47 | 9,863,619.9 |
| 其他应收款合计 | 11,780,116.78 | 21,720,919.97 | 21,350,932.08 | 390,848.02 |
| 存货 | 116,702,724.85 | 103,245,887.36 | 110,707,955.61 | 110,170,011.11 |
| 其他流动资产 | 7,287,237.86 | 7,430,998.37 | 8,741,299.47 | 8,192,006.66 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,944,260,056.93 | 1,987,411,570.04 | 1,969,155,915.73 | 1,981,489,807.37 |
| 非流动资产: | | | | |
| 固定资产 | 295,057,509.98 | 210,087,025.95 | 211,585,019.63 | 210,802,224.95 |
| 在建工程 | 21,646,451.54 | 90,942,845.74 | 83,120,162.26 | 81,582,803.2 |
| 使用权资产 | 3,689,207.78 | 894,348.93 | 1,149,884.86 | 1,348,296.34 |
| 无形资产 | 66,331,056.58 | 23,587,230.41 | 23,730,690.5 | 23,874,150.59 |
| 长期待摊费用 | 100,278.12 | 39,368.32 | 36,787.16 | 55,260.96 |
| 递延所得税资产 | 4,394,454.15 | 4,720,100.44 | 5,590,381.02 | 4,694,861.1 |
| 其他非流动资产 | 14,140,160.54 | 18,423,121.68 | 8,525,236.26 | 8,302,048.67 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 405,359,118.69 | 348,694,041.47 | 333,738,161.69 | 330,659,645.81 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,349,619,175.62 | 2,336,105,611.51 | 2,302,894,077.42 | 2,312,149,453.18 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 41,960,366.84 | 56,575,251.84 | 48,514,127.75 | 51,673,523.12 |
| 其中：应付票据 | 9,999,585 | 14,682,385 | 16,623,420 | 16,926,620 |
| 应付账款 | 31,960,781.84 | 41,892,866.84 | 31,890,707.75 | 34,746,903.12 |
| 合同负债 | 1,383,215.73 | 1,340,663.47 | 692,791.07 | 2,110,133.63 |
| 应付职工薪酬 | 13,988,900.62 | 11,582,029 | 10,275,608.43 | 6,269,738.5 |
| 应交税费 | 6,166,111.31 | 11,396,056.52 | 10,288,755.75 | 7,903,130.11 |
| 其他应付款合计 | 2,022,789.37 | 1,230,734.56 | 775,235.99 | 504,693.12 |
| 一年内到期的非流动负债 | 1,679,724.75 | 340,020.17 | 452,889.08 | 714,049.11 |
| 其他流动负债 | 3,961,730.21 | 2,428,552.04 | 2,528,988.4 | 1,389,687.17 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 71,162,838.83 | 84,893,307.6 | 73,528,396.47 | 70,564,954.76 |
| 非流动负债: | | | | |
| 租赁负债 | 1,601,611.53 | 529,274.98 | 626,814.49 | 663,590.52 |
| 递延收益 | 7,647,866.67 | 7,906,979.17 | 8,052,095.24 | 8,270,204.17 |
| 递延所得税负债 | 938,242.75 | 826,189.35 | 449,778.07 | 107,044.76 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 10,187,720.95 | 9,262,443.5 | 9,128,687.8 | 9,040,839.45 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 81,350,559.78 | 94,155,751.1 | 82,657,084.27 | 79,605,794.21 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,000,000 | 108,000,000 | 108,000,000 | 108,000,000 |
| 资本公积 | 1,686,279,278.15 | 1,684,490,297.98 | 1,683,177,029.98 | 1,683,177,029.98 |
| 减:库存股 | 42,000,590.49 | 42,000,590.49 | 31,380,551.86 | 9,434,008.5 |
| 专项储备 | 4,436,317.49 | 4,252,782.14 | 3,759,256.68 | 3,278,384.62 |
| 盈余公积 | 49,865,214.63 | 48,702,607.45 | 44,660,697.77 | 46,490,080.64 |
| 未分配利润 | 461,688,396.06 | 438,504,763.33 | 412,020,560.58 | 401,032,172.23 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,268,268,615.84 | 2,241,949,860.41 | 2,220,236,993.15 | 2,232,543,658.97 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,268,268,615.84 | 2,241,949,860.41 | 2,220,236,993.15 | 2,232,543,658.97 |
| 负债和股东权益合计 | 2,349,619,175.62 | 2,336,105,611.51 | 2,302,894,077.42 | 2,312,149,453.18 |
| 公告日期 | 2025-04-11 | 2024-10-30 | 2024-08-28 | 2024-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |